Tanyalak Parimon

Assistant Professor

Cedars-Sinai Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Tanyalak Parimon is an Assistant Professor at Cedars-Sinai Medical Center in the United States. Her research primarily focuses on the mechanisms underlying lung diseases, specifically idiopathic pulmonary fibrosis, and the implications of infections such as influenza and COVID-19 on lung health. Recent publications highlight her work on macrophage activity in lung pathology and the role of extracellular vesicles in inflammation and cardiovascular disease.

Articles (11)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (4)

Barry Stripp

Professor

Cedars-Sinai Medical Center

UNITED STATES

View details

Ivan Vujkovic-Cvijin

Assistant Professor

Cedars-Sinai Medical Center

UNITED STATES

View details

Cory Hogaboam

Professor

Cedars-Sinai Medical Center

UNITED STATES

View details

Yingze Zhang

University of Pittsburgh

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tanyalak Parimon

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Caveolin Scaffolding Domain (CSD) Peptide LTI-2355 Modulates the Phagocytic and Synthetic Activity of Lung-Derived Myeloid Cells in Idiopathic Pulmonary Fibrosis (IPF) and Post-Acute Sequelae of COVID Fibrosis (PASC-F)

Interstitial Macrophages Mediate Efferocytosis of Alveolar Epithelium during Influenza Infection

Antibiotic use during influenza infection augments lung eosinophils that impair immunity against secondary bacterial pneumonia

Senescence of alveolar epithelial progenitor cells: a critical driver of lung fibrosis

Potential mechanisms for lung fibrosis associated with COVID-19 infection

Understanding Interstitial Lung Diseases Associated with Connective Tissue Disease (CTD-ILD): Genetics, Cellular Pathophysiology, and Biologic Drivers

Extracellular Vesicles, Inflammation, and Cardiovascular Disease

Current Therapeutics for COVID-19, What We Know about the Molecular Mechanism and Efficacy of Treatments for This Novel Virus

ALCAM Makes It All Calm by Inhibiting Apoptosis

Cellular Senescence: Pathogenic Mechanisms in Lung Fibrosis

Diagnostic and Therapeutic Applications of Extracellular Vesicles in Interstitial Lung Diseases

Collaborators (4)

Barry Stripp

Ivan Vujkovic-Cvijin

Cory Hogaboam

Yingze Zhang

Make your next move.